Drugs like alirocumab and evolocumab can lower bad cholesterol by more than half in people with a genetic cholesterol problem, and they keep working well for over a year with regular use.

According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.